Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nakamoto Inc.NAKA · Entity 6621 | Director · Chief Medical Officer | September 22, 2025 | September 24, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nakamoto Inc.
Report date September 22, 2025 · Filed September 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 191,271 |
Ending reported balance
After 2025-09-22 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-09-22 · Grant · Acquired 37,593 · Balance 136,618 F1: This reflects restricted stock units ("RSUs") that shall time-vest over a four (4) year period, with no vesting during the first twelve (12) months following August 15, 2025 (the "Cliff Period"), and thereafter twenty-five percent (25%) of the RSUs shall vest upon completion of the Cliff Period, with the remaining seventy-five percent (75%) of the RSUs vesting in equal quarterly installments over the subsequent thirty six (36) months, subject to the reporting person's continued service to the issuer through each applicable vesting date. Row 2 · 2025-09-22 · Grant · Acquired 26,129 · Balance 162,747 F2: This reflects a restricted stock award that was fully vested as of September 22, 2025. Row 3 · 2025-09-22 · Grant · Acquired 10,146 · Balance 172,893 F3: This reflects a restricted stock award that was fully vested as of September 22, 2025. Row 4 · 2025-09-22 · Grant · Acquired 18,378 · Balance 191,271 F4: This reflects a restricted stock award that was fully vested as of September 22, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This reflects restricted stock units ("RSUs") that shall time-vest over a four (4) year period, with no vesting during the first twelve (12) months following August 15, 2025 (the "Cliff Period"), and thereafter twenty-five percent (25%) of the RSUs shall vest upon completion of the Cliff Period, with the remaining seventy-five percent (75%) of the RSUs vesting in equal quarterly installments over the subsequent thirty six (36) months, subject to the reporting person's continued service to the issuer through each applicable vesting date.
F2: This reflects a restricted stock award that was fully vested as of September 22, 2025.
F3: This reflects a restricted stock award that was fully vested as of September 22, 2025.
F4: This reflects a restricted stock award that was fully vested as of September 22, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 22, 2025 Filed Sep 24, 2025 21:46 UTC | Nakamoto Inc. NAKA · Entity 6621 | GrantCommon Stock | 18,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-091340 · ownership.xml · nonDerivative · entry 4 Pickett Timothy · CIK 0002002575 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,271 F4 · shares: This reflects a restricted stock award that was fully vested as of September 22, 2025. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 21:46 UTC | Nakamoto Inc. NAKA · Entity 6621 | GrantCommon Stock | 10,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-091340 · ownership.xml · nonDerivative · entry 3 Pickett Timothy · CIK 0002002575 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,893 F3 · shares: This reflects a restricted stock award that was fully vested as of September 22, 2025. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 21:46 UTC | Nakamoto Inc. NAKA · Entity 6621 | GrantCommon Stock | 26,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-091340 · ownership.xml · nonDerivative · entry 2 Pickett Timothy · CIK 0002002575 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,747 F2 · shares: This reflects a restricted stock award that was fully vested as of September 22, 2025. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 21:46 UTC | Nakamoto Inc. NAKA · Entity 6621 | GrantCommon Stock | 37,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-091340 · ownership.xml · nonDerivative · entry 1 Pickett Timothy · CIK 0002002575 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,618 F1 · shares: This reflects restricted stock units ("RSUs") that shall time-vest over a four (4) year period, with no vesting during the first twelve (12) months following August 15, 2025 (the "Cliff Period"), and thereafter twenty-five percent (25%) of the RSUs shall vest upon completion of the Cliff Period, with the remaining seventy-five percent (75%) of the RSUs vesting in equal quarterly installments over the subsequent thirty six (36) months, subject to the reporting person's continued service to the issuer through each applicable vesting date. Read SEC document |
| May 12, 2025 Filed May 14, 2025 20:15 UTC | Nakamoto Inc. KDLY · Entity 6621 | GrantOption · Derivative | 7,479 | $4.29 Strike: $4.29 | $32,084.91 |
DisclosureSEC source: 0001641172-25-010419 · ownership.xml · derivative · entry 2 Pickett Timothy · CIK 0002002575 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,823 Underlying: Common Stock · 7,479 shares Expires 2035-05-12 Read SEC document |
| May 12, 2025 Filed May 14, 2025 20:15 UTC | Nakamoto Inc. KDLY · Entity 6621 | GrantCommon Stock | 28,780 | $1.61 | $46,335.80 |
DisclosureSEC source: 0001641172-25-010419 · ownership.xml · nonDerivative · entry 1 Pickett Timothy · CIK 0002002575 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,025 F1 · date: These shares were issued for services rendered prior to April 1, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.